Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 1/2011

Open Access 01-01-2011 | Original paper

Do changes in cigarette design influence the rise in adenocarcinoma of the lung?

Authors: David M. Burns, Christy M. Anderson, Nigel Gray

Published in: Cancer Causes & Control | Issue 1/2011

Login to get access

Abstract

Background

Incidence rates for adenocarcinoma of the lung are increasing and are higher in the United States than in many other developed countries. We examine whether these trends may be associated with changes in cigarette design.

Methods

Lung cancer risk equations based on observations during 1960–1972 from the American Cancer Society Cancer Prevention Study I are applied to 5-year birth cohort–specific estimates of changes in smoking behaviors to predict birth cohort–specific rates of squamous cell carcinoma and adenocarcinoma of the lung among US White men for the period 1973–2000. These expected rates are compared to observed rates for the same birth cohorts of White men in the US Surveillance, Epidemiology and End Results (SEER) data.

Results

Changes in smoking behaviors over the past several decades adequately explain the changes in squamous cell carcinoma rates observed in the SEER data. However, predicted rates for adenocarcinoma do not match the observed SEER data without inclusion of a term increasing the risk for adenocarcinoma with the duration of smoking after 1965.

Conclusion

The risk of developing squamous cell carcinoma from smoking appears to have remained stable in the United States over the past several decades; however, the risk of adenocarcinoma has increased substantially in a pattern temporally associated with changes in cigarette design.
Literature
1.
Devesa SS, Shaw GL, Blot WJ (1991) Changing patterns of lung cancer incidence by histological type. Cancer Epidemiol Biomarkers Prev 1(1):29–34PubMed
2.
Devesa SS, Bray F, Vizcaino AP, Parkin DM (2005) International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer 117(2):294–299CrossRefPubMed
3.
Wingo PA, Ries LA, Giovino GA, Miller DS, Rosenberg HM, Shopland DR et al (1999) Annual report to the nation on the status of cancer, 1973–1996, with a special section on lung cancer and tobacco smoking. J Natl Cancer Inst 91(8):675–690CrossRefPubMed
4.
Wynder EL, Muscat JE (1995) The changing epidemiology of smoking and lung cancer histology. Environ Health Perspect 103(Suppl 8):143–148CrossRefPubMed
5.
Thun MJ, Lally CA, Flannery JT, Calle EE, Flanders WD, Heath CW Jr (1997) Cigarette smoking and changes in the histopathology of lung cancer. J Natl Cancer Inst 89(21):1580–1586CrossRefPubMed
6.
Zheng T, Holford TR, Boyle P, Chen Y, Ward BA, Flannery J et al (1994) Time trend and the age-period-cohort effect on the incidence of histologic types of lung cancer in Connecticut, 1960–1989. Cancer 74(5):1556–1567CrossRefPubMed
7.
Charloux A, Quoix E, Wolkove N, Small D, Pauli G, Kreisman H (1997) The increasing incidence of lung adenocarcinoma: reality or artefact? A review of the epidemiology of lung adenocarcinoma. Int J Epidemiol 26(1):14–23CrossRefPubMed
8.
Hoffmann D, Rivenson A, Hecht SS (1996) The biological significance of tobacco-specific N-nitrosamines: smoking and adenocarcinoma of the lung. Crit Rev Toxicol 26(2):199–211CrossRefPubMed
9.
10.
Thun MJ, Heath CW Jr (1997) Changes in mortality from smoking in two American Cancer Society prospective studies since 1959. Prev Med 26(4):422–426CrossRefPubMed
11.
Thun MJ, Hannan LM, Adams-Campbell LL, Boffetta P, Buring JE, Feskanich D et al (2008) Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies. PLoS Med 5(9):e185CrossRefPubMed
12.
Thun MJ, Henley SJ, Burns D, Jemal A, Shanks TG, Calle EE (2006) Lung cancer death rates in lifelong nonsmokers. J Natl Cancer Inst 98(10):691–699CrossRefPubMed
13.
Stevens RG, Moolgavkar SH (1984) A cohort analysis of lung cancer and smoking in British males. Am J Epidemiol 119(4):624–641PubMed
14.
Tolley HD, Crane L, Shipley N (1991) Smoking prevalence and lung cancer death rates. In: Shopland D, Burns DM, Samet JM, Gritz ER (eds) Strategies to control tobacco use in the United States: a blueprint for public health action in the 1990s. National Cancer Institute, Bethesda, pp 75–144
15.
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2004: Lyon France), International Agency for Research on Cancer (2007) Smokeless tobacco and some tobacco-specific N-nitrosamines. World Health Organization distributed by WHO Press, Lyon, France, Geneva, Switzerland
16.
Ashley DL, O’Connor RJ, Bernert JT, Watson CH, Polzin GM, Jain RB et al. Effect of differing levels of tobacco-specific nitrosamines in cigarette smoke on the levels of biomarkers in smokers. Cancer Epidemiol Biomarkers Prev
17.
Knoke JD, Burns DM, Thun MJ (2008) The change in excess risk of lung cancer attributable to smoking following smoking cessation: an examination of different analytic approaches using CPS-I data. Cancer Causes Control 19(2):207–219CrossRefPubMed
18.
Knoke JD, Shanks TG, Vaughn JW, Thun MJ, Burns DM (2004) Lung cancer mortality is related to age in addition to duration and intensity of cigarette smoking: an analysis of CPS-I data. Cancer Epidemiol Biomarkers Prev 13(6):949–957PubMed
19.
Burns DM, Lee LL, Gilpin B, Tolley HD, Vaughn J, Shanks T (1997) Cigarette smoking behavior in the United States. In: Burns DM, Garfinkel L, Samet JM (eds) Changes in cigarette related disease risks and their implications for prevention and control. National Cancer Institute, Bethesda, pp 13–112
20.
Anderson CM, Burns DM, Dodd K, Feuer EJ (2010) Birth cohort specific estimates of smoking behaviors for the U.S. population risk analysis (submitted)
21.
Pinsky PF, Miller A, Kramer BS, Church T, Reding D, Prorok P et al (2007) Evidence of a healthy volunteer effect in the prostate, lung, colorectal, and ovarian cancer screening trial. Am J Epidemiol 165(8):874–881CrossRefPubMed
22.
Bennett VA, Davies EA, Jack RH, Mak V, Moller H (2008) Histological subtype of lung cancer in relation to socio-economic deprivation in South East England. BMC Cancer 8:139CrossRefPubMed
23.
Chen F, Bina WF, Cole P (2007) Declining incidence rate of lung adenocarcinoma in the United States. Chest 131(4):1000–1005CrossRefPubMed
24.
Chen F, Cole P, Bina WF (2007) Time trend and geographic patterns of lung adenocarcinoma in the United States, 1973–2002. Cancer Epidemiol Biomarkers Prev 16(12):2724–2729CrossRefPubMed
25.
Chen F, Jackson H, Bina WF (2009) Lung adenocarcinoma incidence rates and their relation to motor vehicle density. Cancer Epidemiol Biomarkers Prev 18(3):760–764CrossRefPubMed
26.
United States Public Health Service, Office of the Surgeon General, National Center for Chronic Disease Prevention and Health Promotion (U.S.) (2004) The health consequences of smoking a report of the Surgeon General. U.S. Public Health Service, National Center for Chronic Disease Prevention and Health Promotion, Atlanta. Available from: http://​purl.​access.​gpo.​gov/​GPO/​LPS49585
27.
Wu-Williams AH, Samet JM (1994) Lung cancer and cigarette smoking. In: Samet JM (ed) Epidemiology of lung cancer. Marcel Decker, New York, pp 71–108
28.
Kreyberg L (1962) Histological lung cancer types. A morphological and biological correlation. Acta Pathol Microbiol Scand Suppl 157:1–92PubMed
29.
30.
Travis WD, Lubin J, Ries L, Devesa S (1996) United States lung carcinoma incidence trends: declining for most histologic types among males, increasing among females. Cancer 77(12):2464–2470CrossRefPubMed
31.
Kenfield SA, Wei EK, Stampfer MJ, Rosner BA, Colditz GA (2008) Comparison of aspects of smoking among the four histological types of lung cancer. Tob Control 17(3):198–204CrossRefPubMed
32.
Hoffmann D, Hoffmann I (1997) The changing cigarette, 1950–1995. J Toxicol Environ Health 50(4):307–364CrossRefPubMed
33.
Gower S, Hammond D (2007) CSP deposition to the alveolar region of the lung: implications of cigarette design. Risk Anal 27(6):1519–1533CrossRefPubMed
34.
Church TR, Anderson KE, Caporaso NE, Geisser MS, Le CT, Zhang Y et al (2009) A prospectively measured serum biomarker for a tobacco-specific carcinogen and lung cancer in smokers. Cancer Epidemiol Biomarkers Prev 18(1):260–266CrossRefPubMed
35.
Yuan JM, Koh WP, Murphy SE, Fan Y, Wang R, Carmella SG et al (2009) Urinary levels of tobacco-specific nitrosamine metabolites in relation to lung cancer development in two prospective cohorts of cigarette smokers. Cancer Res 69(7):2990–2995CrossRefPubMed
36.
Thun MJ, Burns DM (2001) Health impact of “reduced yield” cigarettes: a critical assessment of the epidemiological evidence. Tob Control 10(Suppl 1):i4–i11PubMed
37.
WHO (2008) (TobReg) SGoTPR. The scientific basis of tobacco product regulation. World Health Organisation Technical Report Series (951), pp 1–277 (1 p following)
38.
Harkness EF, Brewster DH, Kerr KM, Fergusson RJ, MacFarlane GJ (2002) Changing trends in incidence of lung cancer by histologic type in Scotland. Int J Cancer 102(2):179–183CrossRefPubMed
Metadata
Title
Do changes in cigarette design influence the rise in adenocarcinoma of the lung?
Authors
David M. Burns
Christy M. Anderson
Nigel Gray
Publication date
01-01-2011
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 1/2011
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-010-9660-0

Other articles of this Issue 1/2011

Cancer Causes & Control 1/2011 Go to the issue

Original paper

Dietary patterns and breast cancer risk among Chinese women

Brief report

Secondhand smoke exposure in bars and restaurants in Guatemala City: before and after smoking ban evaluation

Original paper

Dietary glycemic index, glycemic load, insulin index, fiber and whole-grain intake in relation to risk of prostate cancer

Original paper

The contribution of postmenopausal hormone use cessation to the declining incidence of breast cancer

Original paper

Vitamin D, calcium, and retinol intake, and pancreatic cancer in a population-based case–control study in the San Francisco Bay area

Original paper

Reduction in arsenic intake from water has different impacts on lung cancer and bladder cancer in an arseniasis endemic area in Taiwan
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits